Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection : reversion by antiviral treatment with pegylated IFNalpha and ribavirin

Co-infection with HCV and HIV-1 is a problem of increasing importance and the role of innate cellular immunity in this co-infection is incompletely understood. Here, we have observed sharply elevated numbers of CD56(-)CD16(+) perforin(low) NK cells in HCV/HIV-1 co-infected subjects on antiretroviral...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 128(2008), 1 vom: 15. Juli, Seite 46-56
1. Verfasser: Gonzalez, Veronica D (VerfasserIn)
Weitere Verfasser: Falconer, Karolin, Michaëlsson, Jakob, Moll, Markus, Reichard, Olle, Alaeus, Annette, Sandberg, Johan K
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2008
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Antiviral Agents CD56 Antigen Interferon alpha-2 Interferon-alpha Recombinant Proteins Polyethylene Glycols 3WJQ0SDW1A mehr... Ribavirin 49717AWG6K peginterferon alfa-2a Q46947FE7K